Dolan Sondhi
Directeur/Membre du Conseil chez PASSAGE BIO, INC.
Fortune : - $ au 31/05/2024
Provenance du réseau au premier degré de Dolan Sondhi
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dolan Sondhi via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| AURORA CANNABIS INC. | Agricultural Commodities/Milling | Director of Finance/CFO | |
| REGENXBIO INC. | Pharmaceuticals: Major | Founder | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ABBVIE INC. | Pharmaceuticals: Major | Sales & Marketing | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
| WWBD-FM | Broadcasting | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| Albion College | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Masters Business Admin | |
| Kalamazoo College | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| Tufts University | College/University | Graduate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
| University of Michigan | College/University | Doctorate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Rockefeller University | College/University | Doctorate Degree | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
| GLOSEL CO., LTD. | Electronic Components | General Counsel | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | General Counsel | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Perelman School of Medicine | College/University | Doctorate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
| F.W. Olin Graduate School of Business | College/University | Masters Business Admin | |
| Yale School of Management | College/University | Masters Business Admin | |
| University of Pittsburgh School of Medicine | College/University | Doctorate Degree | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Founder | |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Intercept Pharma UK & Ireland Ltd.
 Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | Medical Distributors | Director/Board Member | |
Intercept Pharma Deutschland GmbH
 Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | Medical Distributors | Chief Executive Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 37 |
| Suisse | 6 |
| Royaume-Uni | 4 |
| France | 3 |
| Canada | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 20 |
| Commercial Services | 4 |
| Distribution Services | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 45 |
| Corporate Officer/Principal | 25 |
| Independent Dir/Board Member | 20 |
| Director of Finance/CFO | 13 |
| Chief Executive Officer | 12 |
Relations les plus connectées
| Insiders | |
|---|---|
| Maxine Gowen | 23 |
| Sandipkumar S. Kapadia | 19 |
| Athena Countouriotis | 17 |
| Saqib Islam | 15 |
| Derrell Porter | 14 |
| Alex Fotopoulos | 7 |
| Desiree Luthman | 7 |
| James M. Wilson | 6 |
| Simona King | 6 |
| Stuart M. Henderson | 5 |
| Edgar Cale | 5 |
| William Chou | 5 |
| Mark Forman | 4 |
| Kathleen Borthwick | 3 |
| Andrea Campanile | 1 |
- Bourse
- Insiders
- Dolan Sondhi
- Connexions Sociétés
